Clinical trials
Completed Observational Ventricular Fibrillation trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 4 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boston Scientific Corporation | 7 |
| Biotronik SE & Co. KG | 4 |
| Medtronic Cardiac Rhythm and Heart Failure | 4 |
| Guidant Corporation | 3 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Columbia University | 1 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 1 |
| French Defence Health Service | 1 |
| Hospices Civils de Lyon | 1 |
| Hospital San Carlos, Madrid | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ventricular Fibrillation | 41 |
| Tachycardia, Ventricular | 27 |
| Death, Sudden, Cardiac | 13 |
| Heart Failure | 10 |
| Atrial Fibrillation | 6 |
| Heart Arrest | 6 |
| Arrhythmias, Cardiac | 5 |
| Heart Diseases | 4 |
| Cardiovascular Diseases | 3 |
| Myocardial Infarction | 3 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.